Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma

计划入组 27 人 · 首次发布于 2024 年 5 月 17 日

Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

首次发布于 2018 年 4 月 10 日

Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

计划入组 24 人 · 首次发布于 2013 年 11 月 8 日

NANT Squamous Cell Carcinoma Vaccine

GPR87 antagonists (squamous cell carcinoma)

NUCC-0227383

Cutis Academy of Cutaneous Sciences

India

Gamida Cell

Israel

GAMIDA CELL INC.

United States

FDA Approves Checkpoint Therapeutics' Unloxcyt for Advanced Cutaneous Squamous Cell Carcinoma

Sun Pharma Reports Durable Responses with UNLOXCYT in Advanced Skin Cancer at ASCO 2026

Fortress Biotech Highlights FDA Approval of Emrosi and Cosibelimab's Upcoming PDUFA Date